Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis.

ABSTRACT: (1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this gender gap is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female and male CF patients are analyzed in order to determine the pathways related to sex-biased genes and assess their potential influence on sex-specific effects in CF patients. (3) Results: We identify sex-biased genes in female and male CF patients and provide explanations for some sex-specific differences at the molecular level. (4) Conclusion: Genes in key pathways associated with CF are differentially expressed between sexes, and thus may account for the gender gap in morbidity and mortality in CF.

SUBMITTER: Gartner C 

PROVIDER: S-EPMC10304421 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature